This cross-sectional multiple-center study adapts an anatomical scoring system for use with registry data, allowing facile and automatic calculation of scores and association with clinical outcomes among patients undergoing percutaneous or surgical revascularization.
This cohort study assesses changes in nonhyperemic and hyperemic hemodynamic stenosis and resistance indices in nonculprit vessels in patients with ST-segment elevation myocardial infarction (STEMI).
This network meta-analysis of randomized controlled trials examines the safety and efficacy of different antithrombotic regimens.
This study assesses whether a history of warfarin therapy in patients with atrial fibrillation is independently associated with subsequent bleeding or thrombotic events.
This meta-analysis of 21 randomized clinical trials examines the role of vitamin D supplementation in reducing cardiovascular events and all-cause mortality.
This secondary analysis of a randomized clinical trial assesses whether a 12-week endurance or resistance training intervention can regulate epicardial and pericardial adipose tissue mass.
This population-based study uses mendelian randomization to evaluate whether there is an association between elevated systolic blood pressure and valvular heart disease.
This case-control study uses existing medical records and autopsy data to assess the prevalence of silent myocardial infarction and electrocardiographic abnormalities in individuals who experienced sudden cardiac death without a prior diagnosis of coronary artery disease.
This population-based study describes use of the cardiac resynchronization therapy defibrillator when the 2012 American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines for device-based therapy of cardiac rhythm abnormalities were revised.
This post hoc analysis of a randomized clinical trial compares outcomes after transcatheter vs surgical aortic valve replacement in patients at intermediate operative risk with a history of coronary artery bypass graft surgery.
This study examines the insurance coverage and out-of-pocket costs to Medicare beneficiaries for the angiotensin receptor–neprilysin inhibitor sacubitril/valsartan.
This Viewpoint describes the means by which sudden cardiac death arises in patients who have implantable cardioverter-defibrillators.
This Viewpoint discusses how antivaccination sentiment has extended to use of statins and outlines ways physicians can combat antistatin misinformation.
This essay describes 2 decades of life with an implantable pacemaker-defibrillator, including the author’s loss of all underlying heart rhythm.
This narrative review provides guidance to clinicians on initiation, selection, maintenance, and weaning or withdrawal of chronic inotropes and the management of concurrent therapies in the modern heart failure landscape.
A 44-year-old woman presents with dilated cardiomyopathy after ventricular fibrillation arrest and receives several shocks from an impanted subcutaneous cardioverter defibrillator. What would you do next?
This Clinical Guidelines Synopsis summarizes the 2018 American College of Cardiology/American Heart Association/Heart Rhythm Society Guideline on Bradycardia and Conduction Delay and reviews recommendations for permanent pacing.
Create a personal account or sign in to: